Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 13,130.10 -115.13 -0.87%
Hang Seng 20,458.20 -528.72 -2.52%
S&P/ASX 200 4,741.60 -119.78 -2.46%
  • Exchange: ASE
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Cardiovascular Devices

ImpediMed Ltd

+ Add to Watchlist

IPD:AU

0.1000 AUD 0.0150 13.04%

As of 23:50:46 ET on 06/19/2013.

Company Profile for ImpediMed Ltd (IPD)

ImpediMed Limited develops and sells internationally, non-invasive medical devices for diagnosing and monitoring human disorders and diseases, particularly in cancer survivors.

Contact Information

ImpediMed Ltd

Unit 1, 50 Parker Court
Pinkenba, QLD 4008
Australia
Phone: 61-7-3860-3700

Key Executives for ImpediMed Ltd (IPD)

Richard Carreon "Rick"President/CEOMorten VigelandVP:Global Finance
Belinda RobinsonVP:Intl SalesCatherine KingsfordVP:Quality Clinical Trials
Dennis SchlahtVP:Xitron Test & MeasurementGregory Wayne Brown "Greg"Executive Director
Stephen Anthony DenaroSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil